| Identification | Back Directory | [Name]
Methyl 6-[[[(2-Chloroethyl)amino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside | [CAS]
58994-95-9 | [Synonyms]
Methyl 6-[[[(2-Chloroethyl)amino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside Methyl 6-[[[(2-Chloroethyl)amino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside α-D-Glucopyranoside, methyl 6-[[[(2-chloroethyl)amino]carbonyl]amino]-6-deoxy- | [Molecular Formula]
C10H19ClN2O6 | [MOL File]
58994-95-9.mol | [Molecular Weight]
298.72 |
| Chemical Properties | Back Directory | [Boiling point ]
566.3±50.0 °C(Predicted) | [density ]
1.44±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
Dichloromethane; Ethanol; Methanol | [form ]
Foam | [pka]
12.96±0.70(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Uses]
Methyl 6-[[[(2-Chloroethyl)amino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins. |
|
|